Board of Directors

Darrin R. Uecker
Chief Executive Officer, President & Director
Darrin R. Uecker has been our Chief Executive Officer and President and a Director since September 2015. Mr. Uecker has over 20 years of experience in the medical device field and is a named inventor on over 60 patents. Prior to Pulse Biosciences Mr. Uecker was the President and Chief Operating Officer of Progyny, Inc., Menlo Park, California, a company that developed EevaTM, the world’s first automated time-lapse system for embryo selection during in-vitro fertilization. Prior to that Mr. Uecker was the Chief Executive Officer and President and a Director of Gynesonics, Inc., Redwood City, California, a company that developed a novel medical device for the treatment of symptomatic uterine fibroids using ultrasound guided radio frequency ablation. Mr. Uecker has served in a variety of executive level roles at CyperHeart, Inc., Conceptus, Inc., RITA Medical Systems, Inc., and Computer Motion, Inc. Mr. Uecker attended the University of California at Santa Barbara where he received a B.S. and M.S. in electrical and computer engineering.



Robert M. Levande
Chairman
Robert M. Levande has been a director since May 2014 and chairman of the board since July 2014. He served as our vice president from May 2014 until September 2015. Mr. Levande is a senior managing director at MDB Capital Group, LLC, which he joined in 2003. Prior to joining MDB Capital Group, LLC, Mr. Levande was co-head of Life Sciences Corporate Finance at Gilford. Previously, he founded the Palantir Group, Inc., which specializes in providing strategic advice in business development, mergers, acquisitions, and capital raising for the medical technology industry. From 1972 through 1999, Mr. Levande held a number of executive positions of increasing responsibility with Pfizer Inc., principally in its Medical Technology Group (MTG), encompassing general management, operations, finance, marketing, and business development. Mr. Levande's other experience includes serving as a director of Orthovita, Inc. (NASDAQNM: VITA) and being the founder / director of VirnetX Inc. (now VirnetX Holding Corp. (NYSE: MKT: VHC). He currently is a director of Integrated Surgical Systems (OTC: ISSM.PK). Mr. Levande holds an M.B.A. from Columbia University and a B.S. in Economics from the University of Pennsylvania Wharton School of Finance & Commerce.



Mitchell E. Levinson
Director
Mitchell E. Levinson has been a director since January 2015. Mr. Levinson was the start-up CEO for Zeltiq Aesthetics Inc. when the company was founded in 2005 and served as its president and its chief executive officer from September 2005 until September 2009. He stayed on as Chief Scientific Officer from September 2009 through December 2010 to help transition the company. Prior to Zeltiq he served as Vice President of Research and Development of Thermage, Inc. (later renamed Solta Medical), a company engaged in cosmetic tissue tightening devices. Mr. Levinson served as the Vice President of Engineering for BioSurgical Corporation (acquired by Baxter), a company which developed novel and proprietary fibrin sealant applicator technology. He also served in senior management roles at Nellcor Puritan Bennett, Baxter Diagnostics, Inc., MicroScan Division, Baxter Healthcare, Alcoa and Hewlett-Packard. He is the inventor of 31 issued and numerous pending U.S. patents. Mr. Levinson earned his BS in Mechanical Engineering from University of California at San Diego and holds an M.S in Computer Systems from the University of Phoenix.



Robert  J. Greenberg, M.D., Ph.D.
Director
Dr. Robert J. Greenberg, M.D., Ph.D. has been one of our directors since May 2015. He served as President, Chief Executive Officer and Director of Second Sight Medical Products, Inc. from December 1998 through August 2015. Since August 2015, he has served as the chairman of the board at Second Sight. Prior to the formation of Second Sight, Dr. Greenberg worked co-managing the Alfred E. Mann Foundation and is currently the chairman of the foundation. Dr. Greenberg served as a lead reviewer for IDEs and 510(k)s at the Office of Device Evaluation at the United States Food and Drug Administration in the Neurological Devices Division. Dr. Greenberg received his Ph.D and M.D. from Johns Hopkins University. His undergraduate degree was in Electrical Engineering and Biomedical Engineering from Duke University.



Thierry Thaure
Director
Mr. Thierry Thaure has been one of our directors since June 2015. In November 2012 he co-founded Cephea Valve Technologies, a company that has developed a percutaneous Mitral Valve replacment technology, and has been the Chief Executive Officer since its inception. Mr. Thaure was Chief Executive Officer of Mauna Kea Technologies, Inc., a global medical device company focused on leading innovation in endomicroscopy. Previously, he served as a director of Mauna Kea. Mr. Thaure also served as the Chief Executive Officer of EndoGastric Solutions Inc. (formerly EsophyX Inc.). Mr. Thaure served as the Executive Vice President of Sales and Marketing of Accuray Incorporated and Vice President of Sales and Marketing of Intuitive Surgical Inc. He also has served in leadership roles at laparoscopic innovator Origin Medsystems and angioplasty leader Advanced Cardiovascular System, both of which became divisions of the Guidant Corporation. Mr. Thaure started his medical device career at Bentley and Edwards Laboratories in the engineering departments, which is a part of Baxter International. Mr. Thaure holds B.S. in Chemistry and Biomedical Engineering from Duke University and his M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University.